Welcome to the investor relations center of Accelerate Diagnostics, Inc. Here you will find a wealth of information regarding the company’s performance to date, recent filings, and our strategy for the continued growth of our business.
Accelerate Diagnostics, Inc. is an in-vitro diagnostics company dedicated to providing solutions for the global challenge of antibiotic resistance and hospital acquired infections. Our focus is developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens.
If you have questions or comments please contact our Investor Relations team by clicking here. We will be happy to help!
May 15, 2017
Accelerate Diagnostics Announces Closing of $79.3 Million Upsized Offering
May 9, 2017
Accelerate Diagnostics Announces Pricing of Upsized Public Offering of Common Stock
May 8, 2017
Accelerate Diagnostics Announces Proposed Public Offering of Common Stock